Literature DB >> 32433223

Procalcitonin as a Biomarker of Unresponsiveness to Intravenous Immunoglobulin for Kawasaki Disease.

Nami Nakamura1, Taichiro Muto, Yu Masuda, Shingo Numoto, Shunsuke Kodama, Ryosuke Miyamoto, Kenji Miyata, Tomohito Hayakawa, Hiromitsu Mori, Yoshiyuki Kuroyanagi, Mitsuko Akaihata, Hideyuki Iwayama, Hirokazu Kurahashi, Yasuhito Shimomura, Takuhito Nagai, Toshinori Hori, Hiroatsu Agata, Akihisa Okumura.   

Abstract

OBJECTIVE: To investigate the usefulness of procalcitonin (PCT) as predictive factors of intravenous immunoglobulin (IVIG)-resistant Kawasaki disease patients.
METHODS: We retrospectively analyzed the laboratory data from 215 children with Kawasaki disease treated with IVIG from 2014 to 2019. We analyzed the clinical and laboratory parameters just before the IVIG including serum levels of PCT with respect to the IVIG response.
RESULTS: Eventually, 127 patients were analyzed. The median age was 2.4 years. IVIG was effective in 108 children (responders) and was ineffective in 19 (non-responders). Serum PCT concentration was higher in non-responders than those of responders (P < 0.001). Multivariate logistic regression analyses indicated that higher PCT concentration (odds ratio 1.34, 95% confidence interval 1.10-1.64) were associated with IVIG resistance. Analyses of the receiver operating characteristic curve showed that the cutoff value of PCT 2.18 ng/mL had 46.4% of sensitivity and 93.9% of specificity. Receiver operating characteristic analysis yielded an area under the curve of 0.82 (0.72-0.92) to predict IVIG resistance.
CONCLUSIONS: Serum PCT value can be an excellent biomarker for predicting unresponsiveness to IVIG with a good discriminatory ability as well as the existing prediction scores.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32433223     DOI: 10.1097/INF.0000000000002716

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  1 in total

1.  [Association of liver damage with coronary artery lesion and no response to intravenous immunoglobulin in the acute stage of Kawasaki disease].

Authors:  Hui-Min Hu; Xiao-Zheng Chen; Yong-Lan Zhang; Zhong-Dong DU
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.